Coreweave Upgraded, IBM Initiated: Wall Street’s Top Analyst Calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly Top 5 Upgrades: - Truist upgraded CoreWeave (CRWV) to Buy from Hold with a price targe

The most talked about and market moving research calls around Wall Street are now in one place.

Here are today’s research calls that investors need to know, as compiled by The Fly

Top 5 Upgrades: – Truist upgraded CoreWeave (CRWV) to Buy from Hold with a price target of $126, down from $131. As more enterprises move toward open models and sovereign AI, the firm believes demand for compute will only increase, benefiting CoreWeave, though shares trade at a significant discount to neoclouds despite the company’s “leadership position.” – Stifel upgraded DigitalOcean (DOCN) to Buy from Hold with a price target of $160, up from $135. The firm cites valuation for the upgrade with the shares down 30% from recent highs. – Wells Fargo upgraded Idacorp (IDA) to Equal Weight from Underweight with a price target of $154, up from $121.

Wells’ higher estimates indicate the shares are cheaper than it screens. – Wells Fargo upgraded NorthWestern Energy (NWE) to Equal Weight from Underweight with a price target of $62, up from $54. The pending merger with Black Hills (BKH) has cleared every hurdle except Montana, the firm tells investors in a research note. – TD Cowen upgraded Genmab (GMAB) to Buy from Hold with a price target of $43, up from $32. The firm is confident that Epkinly, rinatabart sesutecan and petosemtamab will offset Genmab’s $3.6B Darzalex patent cliff.

Leave a Reply

Your email address will not be published. Required fields are marked *